The spectrum of building-related airway disorders: Difficulty in retrospectively diagnosing building-related asthma

Chest

Volumn 128, Issue 3, 2005, Pages 1720-1727

  Brooks, Stuart M ^a,b   Spaul, Wil ^a   McCluskey, James D ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Building related asthma; Environmental tobacco smoke; Formaldehyde; Indoor air quality; Irritant induced asthma

Indexed keywords

FORMALDEHYDE; IRRITANT AGENT; METHACHOLINE; TOBACCO SMOKE;

ADULT; AIR QUALITY; AIRBORNE PARTICLE; ALLERGY; ARTICLE; BUILDING; BUILDING RELATED AIRWAY DISORDER; BUILDING RELATED ASTHMA; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL FEATURE; EAR DISEASE; EMPLOYEE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; MALE; NOSE IRRITATION; OCCUPATIONAL ASTHMA; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; PATHOGENESIS; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT DISEASE; ROOM VENTILATION; THROAT DISEASE;

EID: 24944545550     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.3.1720     Document Type: Article

References (44)

1. Institute of Medicine, Committee on Damp Indoor Spaces and Health, Board on Health Promotion and Disease Prevention. Damp indoor spaces and health. Washington, DC: National Academy Press, 2004
2. Hoffman RE, Wood RC, Kreiss K. Building-related asthma in Denver office workers. Am J Public Health 1993; 83:89-93
3. Institute of Medicine, Committee on the Assessment of Asthma and Indoor Air, Division of Health Promotion and Disease Prevention. Asthma and nonresidential indoor environments. Clearing the air: asthma and indoor exposures. Washington, DC: National Academy Press, 2000; 316-326
4. Ross MA, Curtis L, Scheff PA, et al. Association of asthma symptoms and severity with indoor bioaerosols. Allergy 2000; 55:705-711
5. Wieslander G, Norback D, Bjomsson E, et al. Asthma and the indoor environment: the significance of emission of formaldehyde and volatile organic compounds from newly painted indoor surfaces. Int Arch Occup Environ Health 1997; 69: 115-124
6. National Institute for Occupational Safety and Health. NIOSH manual of analytical methods. Cincinnati, OH; National Institute for Occupational Safety and Health. 1986
7. Clayton GD and associates. Design of ventilation systems. US Department of Health Education and Welfare CDC, NIOSH, ed. The industrial environment: its evaluation and control. Washington, DC: US Government Printing Office. 1973; 609-628
8. Brooks SM. The evaluation of occupational airways disease in the laboratory and workplace. J Allergy Clin Immunol 1982; 70:56-66
9. American Thoracic Society. Standardization of spirometry: 1987 update; ATS statement. Am Rev Respir Dis 1987; 136:1285-1298
10. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies; ATS statement. Am Rev Respir Dis 1991; 144:1202-1218
11. Cockcroft DW, Killian DN, Mellon JJ, et al. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 71:235-243
12. Brooks SM, Bernstein IL, Raghuprasad PK, et al. Assessment of airway hyperresponsiveness in chronic stable asthma. J Allergy Clin Immunol 1990; 85:17-26
13. ASHRAE Standard 62-1999: ventilation for acceptable indoor air quality. Atlanta, GA: American Society of Heating, Refrigerating, and Air-Conditioning Engineers, 1999
14. Menzies D, Bourbeau J. Building-related illnesses. N Engl J Med 1997; 337:1524-1531
15. Norback D, Walinder R, Wieslander G, et al. Indoor air pollutants in schools: nasal patency and biomarkers in nasal lavage. Allergy 2000; 55:163-170
16. Harrison PTC. Indoor air pollution. In: D'Amato G, Holgate ST, eds. The impact of air pollution on respiratory health. Huddersfield, UK: Charlesworth Group, 2002; 117-132
17. Main DM, Hogan TJ. Health effects of low-level exposure to formaldehyde. J Occup Med 1983; 25:896-900
18. Krakowiak A, Gorski P, Pazdrak K, et al. Airway response to formaldehyde inhalation in asthmatic subjects with suspected respiratory formaldehyde sensitization. Am J Ind Med 1998; 33:274-281
19. Norback D, Bjornsson E, Janson C, et al. Asthmatic symptoms and volatile organic compounds, formaldehyde, and carbon dioxide in dwellings. Occup Environ Med 1995; 52:388-395
20. Reynolds SJ, Black DW, Bonn SS, et al. Indoor environmental quality in six commercial office buildings in the Midwest United States. Appl Occup Environ Hyg 2001; 16:1065-1077
21. Thorn J, Brisman J, Toren K. Adult-onset asthma is associated with self-reported mold or environmental tobacco smoke exposures in the home. Allergy 2001; 56:287-292
22. Wolkoff P, Clausen PA, Wilkins CK, et al. Formation of strong airway irritants in terpene/ozone mixtures. Indoor Air 2000; 10:82-91
23. Li TH, Turpin BJ, Shields HC, et al. Indoor hydrogen peroxide derived from ozone/d-limonene reactions. Environ Sci Technol 2002; 36:3295-3302
24. Institute of Medicine, Committee on the Assessment of Asthma and Indoor Air, Division of Health Promotion and Disease Prevention. Asthma and nonresidential indoor environments. Clearing the air: asthma and indoor exposures. Washington, DC: National Academy Press, 2000; 298-315
25. Lemiere C, Cartier A, Dolovich J, et al. Outcome of specific bronchial responsiveness to occupational agents after removal from exposure. Am J Respir Crit Care Med 1996; 154:329-333
26. Malo JL, Ghezzo H. Recovery of methacholine responsiveness after end of exposure in occupational asthma. Am J Respir Crit Care Med 2004; 169:1304-1307
27. Enarson DA, Vedal S, Schulzer M, et al. Asthma, asthma-like symptoms, chronic bronchitis, and the degree of bronchial hyperresponsiveness in epidemiologic surveys. Am Rev Respir Dis 1987; 136:613-617
28. Lemiere C, Malo JL, Boutet M. Reactive airways dysfunction syndrome due to chlorine: sequential bronchial biopsies and functional assessment. Eur Respir J 1997; 10:241-244
29. Brooks SM, Weiss MA, Bernstein IL. Reactive airways dysfunction syndrome (RADS): persistent asthma syndrome after high level irritant exposure. Chest 1985; 88:376-384
30. National Institute of Health. Guideline for the diagnosis and management of asthma. Bethesda, MD: National Heart Lung and Blood Institute, 1997; 1-153
31. Crimi E, Spanevello A, Neri M, et al. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998; 157:4-9
32. Maghni K, Lemiere C, Ghezzo H, et al. Airway inflammation after cessation of exposure to agents causing occupational asthma. Am J Respir Crit Care Med 2004; 169:367-372
33. Beckett PA, Howarth PH. Pharmacotherapy and airway remodelling in asthma? Thorax 2003; 58:163-174
34. Durham SR, Graneek BJ, Hawkins R, et al. The temporal relationship between increases in airway responsiveness to histamine and late asthmatic responses induced by occupational agents. J Allergy Clin Immunol 1987; 79:398-406
35. Smith AB, Brooks SM, Blanchard J, et al. Absence of airway hyperreactivity to methacholine in a worker sensitized to toluene diisocyanate (TDI). J Occup Med 1980; 22:327-331
36. Desjardins A, de Luca S, Cartier A, et al. Nonspecific bronchial hyperresponsiveness to inhaled histamine and hyperventilation of cold dry air in subjects with respiratory symptoms of uncertain etiology. Am Rev Respir Dis 1988; 137:1020-1025
37. Pattemore PK, Asher MI, Harrison AC, et al. The interrelationship among bronchial hyperresponsiveness, the diagnosis of asthma, and asthma symptoms. Am Rev Respir Dis 1990; 142:549-554
38. Dales RE, Nunes F, Partyka D, et al. Clinical prediction of airways hyperresponsiveness. Chest 1988; 93:984-986
39. Baur X, Huber H, Degens PO, et al. Relation between occupational asthma case history, bronchial methacholine challenge, and specific challenge test in patients with suspected occupational asthma. Am J Ind Med 1998; 33:114-122
40. Boulet LP. Asymptomatic airway hyperresponsiveness: a curiosity or an opportunity to prevent asthma? Am J Respir Crit Care Med 2003; 167:371-378
41. Toren K, Brisman J, Jarvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires: a literature review. Chest 1993; 104:600-608
42. Johnson AR, Dimich-Ward HD, Manfreda J, et al. Occupational asthma in adults in six Canadian Communities. Am J Respir Crit Care Med 2000; 162:2058-2062
43. Adelroth E, Hargreave FE, Ramsdale EH. Do physicians need objective measurements to diagnose asthma? Am Rev Respir Dis 1986; 134:704-707
44. Anees W, Huggins V, Pavord ID, et al. Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants. Thorax 2002; 57:231-236